These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Hyperplasiogenic polyps and risk of stomach cancer].
    Author: Bosseckert H, Kratzsch KH, Machnik G, Raabe G, Waller H, Winkelvoss H, Stibenz J, Eichhorn K, Lichteblau A.
    Journal: Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):1-9. PubMed ID: 3286216.
    Abstract:
    In 731 hyperplasiogenic polyps which have been removed by endoscopical polypectomy there were 9 polyps with an early cancer and 8 polyps with severe dysplasias (borderline lesions) as well as 1 polyp, in which an advanced carcinoma has been developed. This is the outstanding greatest number of hyperplasiogenic polyps with a malignant transformation. In addition in 9 patients with hyperplasiogenic polyps carcinomas could be discovered, i.e. a rate for malignant developments of 3.7%. It seems that stomachs with multiple polyps are endangered in particular. The recurrence rate of follow-up examinations covering a period of up to 8 years was 36.1%.
    [Abstract] [Full Text] [Related] [New Search]